Enterprise Therapeutics
is an England drug discovery company that researches and develops novel therapies for the treatment of respiratory diseases... Read moreEnterprise Therapeutics
is an England drug discovery company that researches and develops novel therapies for the treatment of respiratory diseases... Read more
News
Nov 19, 2024
StreetInsider
Press Release: Enterprise Therapeutics : Enterprise Therapeutics Publishes on Medicinal Chemistry of ETD001, a Novel Inhaled ENaC Blocker for Treatment of Cystic Fibrosis
Sep 26, 2024
Manufacturing Chemist
Enterprise Therapeutics: Enterprise Therapeutics bags RPD designation from the FDA for cystic fibrosis therapy
Jun 12, 2024
Business Wire
Press Release: Enterprise Therapeutics : Enterprise Therapeutics Publishes Preclinical Profile of ETD001, a Novel Inhaled ENaC Blocker
Jan 30, 2024
FinSMEs
Enterprise Therapeutics: Enterprise Therapeutics Closes 26M Series B Follow-on Financing
Jan 30, 2024
European Biotechnology
Enterprise Therapeutics: 26m for Cystic Fibrosis Drug Trial
Jan 29, 2024
Endpoints News
Enterprise Therapeutics: Exclusive: UK biotech raises $33.1M to test CF drug that could work on top of standard of care
Jun 14, 2021
MarketScreener
Enterprise Therapeutics: Enterprise Therapeutics doses first subjects in Phase I trial for novel cystic fibrosis therapy ETD001
Oct 08, 2020
Manufacturing Chemist
Enterprise Therapeutics: Enterprise TMEM16A potentiator program acquired by Roche
Oct 07, 2020
The Pharma Letter
Enterprise Therapeutics: Enterprise Therapeutics' first-in-class TMEM16A potentiator program acquired by Roche
Oct 07, 2020
MarketScreener
Enterprise Therapeutics: IP : Investee Sells Developing Drug Portfolio for GBP75 Million
Enterprise Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10